Deaths of despair' caused by drug overdoses, suicide and liver disease due to alcoholism have risen among Americans of color.

And sadly, a lot of Douglas firs may be dying in vain. Mailers increase name recognition, according to a 2014 article in ...

The screening process at our state-of-the-art Drug Discovery ... to see if the drug is safe and tolerated. This is a pilot trial, which if successful, will lead to a bigger study to firmly establish ...

Alana Recovery Center is a top rated Georgia drug rehab program as an outpatient ... integrates evidence based, state-of-the-art treatment using different therapeutic modalities.

Indeed, experts say most people with substance abuse problems put off or even avoid treatment, not only because of the stigma attached to drug treatment programs, but also because many believe ...

Hazelden Betty Ford’s outpatient drug rehab program in the ... we built a brand new state-of-the-art detox unit in 2010. Along with our inpatient treatment program, our 22-bed detox unit is ...

Elsewhere in the building, several patients taking an art ... for all drug use — in other words, decriminalization. It would be combined with an intense focus on harm reduction, treatment ...

has published the first-ever science-based guide to drug addiction treatment. In its Principles of Drug Addiction Treatment: A Research-Based Guide, the institute outlines some of the essential ...

[7,20] Pyrodostigmine is the favored drug by most patients. [7] Ambenonium chloride is an alternative, but is not available everywhere. The optimal treatment should balance effect and dose-related ...

We have completed work on our new state-of-the-art drug discovery centre ... the world’s first ‘Darwinian’ drug discovery programme, designed to tackle cancer’s lethal ability to evolve resistance to ...

“This drug sets a new bar for psoriasis treatment and we are hopeful that trials in treating other diseases triggered by over active Interleukin 17A and Interleukin 17F will also lead to improvements ...

ImmunoGen (IMGN) shares soared higher Tuesday after the cancer drug specialists said its ovarian cancer treatment met the primary goals of a late-stage study. ImmunoGen said mirvetuximab ...